黑料官网

GettyImages-609179959-hero

Cardiovascular Research Center

Michael Widlansky Lab

Michael E. Widlansky, MD, MPH
Professor, Department of Medicine
Principal Investigator
mwidlans@mcw.edu

The Widlansky laboratory work is currently focused on the roles of mircroRNA-29, mitochondrial fission proteins, and the microbiome in the regulation of human vascular endothelial function. It also focuses on studying novel mechanisms of vascular dysfunction in diabetes. His work tests these novel mechanistic insights to determine their relevance to human vascular pathophysiology. In addition, the Widlansky laboratory studies the impact of dietary, pharmacological, and exercise-based interventions on vascular function persons with and without disease. The laboratory also has formed a human vascular research core to foster collaboration with investigators from other disciplines interested in the impact of vascular function on disease states relevant to their fields of interest.

Meet Our Team

Jingli Wang, MD, PhD

Research Scientist II

Justin Westhoff

Research Technologist I

jwesthoff@mcw.edu

Rong Ying, MD

Research Technologist II

Alumni/Former Trainees

Benjamin Hofeld
Mobin Malik

V. K. Puppala
Tisha Suboc

Mike Tanner
Sudhi Tyagi

(Do Couto N, Hidde M, Grigoriadis G, Sparapani R, Durand M, Widlansky M, Jankowski C, Berendt M, Canales B, Golus S, Norwood Toro LE, Laud P, Kong A, Hoskins K, Lewandowski D, Phillips SA, Gutterman DD, Kriegel AJ, Beyer KMM, Beyer AM, Stolley M.) Cardiooncology. 2025 Aug 21;11(1):75 PMID: 40841694 PMCID: PMC12369258 SCOPUS ID: 2-s2.0-105014033548 08/22/2025
(Liu Y, Pandey R, Qiu Q, Liu P, Xue H, Wang J, Therani B, Ying R, Usa K, Grzybowski M, Yang C, Mishra MK, Greene AS, Cowley AW Jr, Rao S, Geurts AM, Widlansky ME, Liang M.) Nat Commun. 2025 Jul 17;16(1):6577 PMID: 40675959 PMCID: PMC12271514 SCOPUS ID: 2-s2.0-105011067559 07/18/2025
(Wolfgram DF, Grassl I, Seigworth C, Widlansky ME, Gao Y.) Hemodial Int. 2025 Jul;29(3):346-353 PMID: 40155364 PMCID: PMC12289419 SCOPUS ID: 2-s2.0-105001140356 03/29/2025
(Nishijima Y, Hader SN, Birch EC, Chen Y, Widlansky ME, Beyer AM.) Cardiovasc Res. 2025 May 23;121(5):699-701 PMID: 39943809 SCOPUS ID: 2-s2.0-105006564276 02/13/2025
(Ray A, Yang C, Stelloh C, Tutaj M, Liu P, Liu Y, Qiu Q, Auer PL, Lin CW, Widlansky ME, Geurts AM, Cowley AW Jr, Liang M, Kwitek AE, Greene AS, Rao S.) Hypertension. 2025 Mar;82(3):476-488 PMID: 39723540 PMCID: PMC12236357 SCOPUS ID: 2-s2.0-85213707759 12/26/2024
(He L, Liu Y, Widlansky ME, Kriegel AJ, Qiu Q, Liang M.) Hypertension. 2025 Feb;82(2):181-184 PMID: 39633557 PMCID: PMC11893092 SCOPUS ID: 2-s2.0-85211732398 12/05/2024
(Cai C, Choy JS, He G, Widlansky ME, Kassab GS, Fan L.) Computers in Biology and Medicine. October 2025;197 SCOPUS ID: 2-s2.0-105016314044 10/01/2025
(Wilcox T, Widlansky ME, Westhoff J, Wang J, Ying R, Thorgerson A, Roberts ML.) Protein Science. June 2025;34(6) SCOPUS ID: 2-s2.0-105005279729 06/01/2025
(Palathinkara M, Aljadah M, Thorgerson A, Dawson AZ, Widlansky ME.) Front Nutr. 2025;12:1495633 PMID: 40093880 PMCID: PMC11906339 SCOPUS ID: 2-s2.0-86000721426 03/17/2025
(Liu Y, Pandey R, Qiu Q, Liu P, Xue H, Wang J, Therani B, Ying R, Usa K, Grzybowski M, Yang C, Mishra MK, Greene AS, Cowley AW Jr, Rao S, Geurts AM, Widlansky ME, Liang M.) bioRxiv. 2024 Oct 14 PMID: 39463975 PMCID: PMC11507733 10/28/2024
(Aljadah M, Khan N, Beyer AM, Chen Y, Blanker A, Widlansky ME.) JACC Adv. 2024 Aug;3(8):101070 PMID: 39055276 PMCID: PMC11269277 07/26/2024
(Aljadah M, Khan N, Beyer AM, Chen Y, Blanker A, Widlansky ME.) Jacc Advances. August 2024;3(8) SCOPUS ID: 2-s2.0-85197318304 08/01/2024

© 2026 黑料官网. All rights reserved. | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.